Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization

被引:128
|
作者
Enskog, A
Henriksson, M
Unander, M
Nilsson, L
Brännström, M
机构
[1] Univ Gothenburg, Dept Anesthesia & Intens Care, Gothenburg, Sweden
[2] Univ Gothenburg, Dept Obstet & Gynecol, Gothenburg, Sweden
关键词
age; allergy; follicle; NF; estradiol; OHSS;
D O I
10.1016/S0015-0282(99)00090-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare patient characteristics and clinical and laboratory parameters in patients in whom ovarian hyperstimulation syndrome (OHSS) develops with those in whom it does not develop. Design: Prospective cohort study. Setting: Reproductive medicine unit at a university medical center. Patient(s): All patients undergoing IVF (n = 428) who received controlled ovarian hyperstimulation during a 6-month period. Intervention(s): Prospective data collection. Main Outcome Measure(s): Patient characteristics (age, body mass index, medical history, smoking habits) and clinical and laboratory data obtained during controlled ovarian hyperstimulation were evaluated in patients who had severe OHSS,any degree of OHSS, or a si,significant risk of OHSS and compared with the remaining populations. Result(s): Severe OHSS developed in 18 patients (4.2%) and mild or moderate OHSS developed in 7.3%. As a group, all the patients with OHSS were significantly younger, received lower doses of gonadotropins, had ovaries containing a higher number of total and large follicles, had a higher number of retrieved oocytes, and increased prevalence of allergy (56% versus 21%) and were more likely to ultimately give birth. Conclusion(s): The observed differences may be useful in elucidating the pathophysiology of OHSS and identifying patients who are at increased risk for OHSS. ( C) 1999 by American Society for Reproductive Medicine.
引用
收藏
页码:808 / 814
页数:7
相关论文
共 50 条
  • [1] Controlled ovarian hyperstimulation in in vitro fertilization
    Abate, A
    Perino, M
    Abate, FG
    Manti, F
    Brigandi, A
    [J]. WOMEN'S HEALTH IN THE 2000: FROM REPRODUCTION TO MENOPAUSE, 1999, : 27 - 32
  • [2] Management of ovarian hyperstimulation syndrome during in vitro fertilization program
    Priou, G
    [J]. CONTRACEPTION FERTILITE SEXUALITE, 1996, 24 (09): : 647 - 649
  • [3] Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization
    Gracia, Clarisa R.
    Morse, Christopher B.
    Chan, Grace
    Schilling, Samantha
    Prewitt, Maureen
    Sammel, Mary D.
    Mandel, Susan J.
    [J]. FERTILITY AND STERILITY, 2012, 97 (03) : 585 - 591
  • [4] INVITRO FERTILIZATION AND THE OVARIAN HYPERSTIMULATION SYNDROME
    MACDOUGALL, MJ
    TAN, SL
    JACOBS, HS
    [J]. HUMAN REPRODUCTION, 1992, 7 (05) : 597 - 600
  • [5] Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal
    Almog, Benny
    Wagman, Israel
    Bibi, Guy
    Raz, Yael
    Azem, Foad
    Groutz, Asnat
    Barkan, Gali
    Holzer, Hananel
    Amit, Ami
    Tulandi, Togas
    Levin, Ishai
    [J]. FERTILITY AND STERILITY, 2011, 95 (08) : 2474 - 2476
  • [6] STATIN USE IN CONTROLLED OVARIAN HYPERSTIMULATION AND IN VITRO FERTILIZATION.
    Estevez, Samantha L.
    Zhuo, Rebecca
    Arcaz, Arthur
    Coughlin, Arielle
    Alkon-Meadows, Tamar
    Hernandez-Nieto, Carlos
    Baird, Morgan
    Lee, Joseph A.
    Copperman, Alan B.
    Friedenthal, Jenna
    [J]. FERTILITY AND STERILITY, 2024, 122 (01) : E27 - E27
  • [7] Severe Ovarian Hyperstimulation Syndrome in the Setting of In Vitro Fertilization Treatment
    Ayllon, Hannia Diaz
    Hernandez, Oscar L.
    Nagi, Talwinder
    Cespedes, Carlos M.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [8] Controlled ovarian hyperstimulation changes the prevalence of serum autoantibodies in in vitro fertilization patients
    Haller, Kadri
    Sarapik, Aili
    Talja, Ija
    Salumets, Andres
    Uibo, Raivo
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2006, 56 (5-6) : 364 - 370
  • [9] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Kahnberg, Annika
    Enskog, Anders
    Brannstrom, Mats
    Lundin, Kersti
    Bergh, Christina
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
  • [10] A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization
    Anserini, P
    Costa, M
    Remorgida, V
    Venturini, PL
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (02) : 75 - 80